An evaluation of the efficacy of curcumin and saffron for the treatment of depressio

Not Applicable

Completed

• Conditions: Depression; Mental Health - Depression; Alternative and Complementary Medicine - Herbal remedies

• Registration Number: ACTRN12615000791538
• Lead Sponsor: Murdoch University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-07-30
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

1. Male or female aged between 18 and 65 years
2. Suffering from depression (mild to moderate severity) as assesed by the Mini International Neuropsychiatric interview
3. Medication-free for at least 3 months (except pharmaceutical antidepressants and contraceptive pill)
4. Non-smoker

Exclusion Criteria

1. Suffer from a diagnosable mental health disorder other than depression e.g., eating disorder, psychosis/ schizophrenia.
2. Suffer from medical illnesses including diabetes, autoimmune diseases, cardiovascular disease, hypertension, chronic fatigue syndrome, asthma.
3. Pregnant or intend to fall pregnant
4. Currently breastfeeding
5. Have suffered from an infection or illness over the last month (includes the common cold)
6. Currently take any antiplatelet (e.g., Aspirin, non-steroidal anti-inflammatories, clopidogrel, dipyridamole, abciximab, tirofiban) and anticoagulant medications (e.g., Warfarin, rivaroxaban, dabigatran etexilate)

Study & Design

• Study Type: Interventional
• Study Design: Not specified